IDDF2022-ABS-0058 Efficacy and response predictors of percutaneous radiofrequency ablation for treatment of intermediate stage hepatocellular carcinoma: a controlled clinical trial
Ragaey Ahmad Eid, Manar Ahmed Kamal, A. Attia, Aliaa Abdel Fattah, Rabab Afify Mohamed, M. Tawfik, A. Haseeb
{"title":"IDDF2022-ABS-0058 Efficacy and response predictors of percutaneous radiofrequency ablation for treatment of intermediate stage hepatocellular carcinoma: a controlled clinical trial","authors":"Ragaey Ahmad Eid, Manar Ahmed Kamal, A. Attia, Aliaa Abdel Fattah, Rabab Afify Mohamed, M. Tawfik, A. Haseeb","doi":"10.1136/gutjnl-2022-iddf.92","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Clinical Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2022-iddf.92","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
